118
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Synergistic effect of polyethylene glycol and superdisintegrant on dissolution rate enhancement of simvastatin in pellet formulation

ORCID Icon, , , , ORCID Icon & ORCID Icon
Pages 720-728 | Received 01 Dec 2018, Accepted 12 Feb 2019, Published online: 26 Mar 2019

References

  • Afrasiabi Garekani H, Ahmadi B, Sadeghi F. 2017. Effect of variation in viscosity grade of ethycellulose on theophylline microcapsule properties prepared by emulsion solvent evaporation. Cdd. 14:73–82.
  • Afrasiabi Garekani H, Nokhodchi A, Amirpour Rayeni M, Sadeghi F. 2013. Preparation and characterization and release properties of Eudragit RS based ibuprofen pellets prepared by extrusionspheronization: effect of binder type and concentration. Drug Dev Ind Pharm. 39:1238–1246.
  • Al-Hamidi H, Edwards AA, Mohammad MA, Nokhodchi A. 2010. To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations. Colloids Surf B Biointerfaces. 76:170–178.
  • Bechgaard H, Nielsen GH. 1978. Controlled-release multiple-units and single-unit doses. A literature review. Drug Dev Ind Pharm. 4:53–67.
  • Bolourchian N, Mahboobian MM, Dadashzadeh S. 2013. The effect of PEG molecular weights on dissolution behavior of simvastatin in solid dispersions. Iran J Pharm Res. 12:11–20.
  • Chamsai B, Sriamornsak P. 2013. Novel disintegrating microcrystalline cellulose pellets with improved drug dissolution performance. J Pharm Sci. 233:278–285.
  • Desai NS, Nagarsenker MS. 2013. Design and evaluation of self-nanoemulsifying pellets of Repaglinide. AAPS PharmSciTech. 14:994–1003.
  • Eskilson C. 1985. Controlled release by microencapsulation. Manuf Chem. 56:33–39.
  • Essa EA, Dwaikat M. 2015. Enhancement of Simvastatin dissolution by surface solid dispersion: effect of carriers and wetting agents. J Appl Pharm Sci. 5:046–053.
  • Goanes A, Martinez-Pacheco R. 2015. New co-processed MCC-based excipient for fast release of low solubility drugs from pellets prepared by extrusion-spheronization. Drug Dev Ind Pharm. 41:362–368.
  • Goyanes A, Souto C, Martinez-Pacheco R. 2011. A comparison of chitosan-silica and sodium starch glycolate as disintegrants for spheronized extruded microcrystalline cellulose pellets. Drug Dev Ind Pharm. 37:825–831.
  • Ibrahim MA, Al-Anazi FK. 2013. Enhancement of the dissolution of albendazole from pellets using MTR technique. Saudi Pharm J. 21:215–223.
  • Ibrahim MA, Mahrous G, El-Badry M, Al-Anazi F. 2011. Indomethacin-loaded pellets prepared by extrusion/spheronization. Effects of cosolvents. Farmacia. 56:483–499.
  • Jachowicz R, Nurnberg E, Pieszczek B, Kluczykowska B, Maciejewska A. 2000. Solid dispersion of ketoprofen in pellets. Int J Pharm. 206:13–21.
  • Javadzadeh Y, Siahi MR, Asnaashari S, Nokhodchi A. 2007. Liquisolid technique as a tool for enhancement of poorly water-soluble drugs and evaluation of their physicochemical properties. Acta Pharm. 57:99–109.
  • Jun SW, Kim MS, Kim JS, Park HJ, Lee S, Woo JS, Hwang SJ. 2007. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process. Eur J Pharm Biopharm. 66:413–421.
  • Patel A, Jones SA, Ferro A, Patel N. 2009. Pharmaceutical salts: a formulation trick or a clinical conundrum. Br J Cardiol. 16:281–286.
  • Patel H, Patel H, Gohel M, Tiwari S. 2016. Dissolution rate improvement of telmisartan through modified MCC pellets using 32 full factorial design. Saudi Pharm J. 24:579–587.
  • Rao M, Mandage Y, Thanki K, Bhise S. 2010. Dissolution improvement of simvastatin by surface solid dispersion technology. Dissolution Technol. 17:27–34.
  • Saripella KK, Loka NC, Mallipeddi R, Rane AM, Neau SH. 2016. A quality by experimental design approach to assess the effect of formulation and process variables on the extrusion and spheronization of drug-loaded pellets containing polyplasdone® XL-10. AAPS PharmSciTech. 17:368–379.
  • Souto C, Rodriguez A, Parajes S, Martinez-Pacheco R. 2005. A comparative study of the utility of two superdisintegrants in microcrystalline cellulose pellets prepared by extrusion-spheronization. Eur J Pharm Biopharm. 61:94–99.
  • Taj Y, Pai RS, Devi VK, Singh G. 2014. Taste masked orally disintegrating pellets of antihistaminic and mucolytic drug: formulation, characterization, and in vivo studies in human. Int Sch Res Notices. 2014:1–8.
  • Taupitz T, Dressman JB, Klein S. 2013. New formulation approaches to improve solubility and drug release from fixed dose combinations: case examples pioglitazone/glimepiride and ezetimibe/simvastatin. Eur J of Pharm Biopharm. 84:208–218.
  • Tho I, Sande SA, Kleinebudde P. 2002. Pectinic acid a novel excipient for production of pellets by extrusion/spheronization: preliminary studies. Eur J Pharm Biopharm. 54:95–99.
  • Varshosas J, Talari R, Mostafavi SA, Nokhodchi A. 2008. Dissolution enhancement of gliclazide using in situ micronization by solvent change method. Powder Technol. 187:222–230.
  • Verheyen P, Steffens KJ, Kleinebudde P. 2009. Use of crospovidone as pelletization aid as alternative to microcrystalline cellulose: effects on pellet properties. Drug Dev Ind Pharm. 35:1325–1332.
  • Wlosnewski JC, Kumpugdee-Vollrath M, Sriamornsak P. 2010. Effect of drying technique and disintegrant on physical properties and drug release behaviour of microcrystalline cellulose-based pellets prepared by extrusion/spheronization. Chem Eng Res Des. 88:100–108.
  • Wrzesinski A, Bertrand H, Moses M, Zhang Y. 2010. Comparision of superdisintegrants in orally disintegrating tablets. AAPS PharmSciTech. 34:100–108.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.